Author:
Luisetti Maurizio,Balfour-Lynn Ian M.,Johnson Simon R.,Miravitlles Marc,Strange Charlie,Trapnell Bruce C.,van Bronswijk Hans,Vogelmeier Claus
Subject
Pulmonary and Respiratory Medicine
Reference68 articles.
1. The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases;Miyamoto;Orphanet J Rare Dis,2011
2. Public Law 107–280—NOV. 6, 2002. US Rare Diseases Act of 2002.
3. National Institutes of Health Office of Rare Diseases Research. http://rarediseases.info.nih.gov/Resources/Rare_Diseases_Information.aspx; 2011 [accessed 12.03.11].
4. European Commission on public heath: rare disease. http://ec.europa.eu/health-eu/health_problems/rare_diseases;
5. March 2011 [accessed 11.03.11].
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献